ORTHO EVRA birth control is a weekly birth control patch. In November 2001, the first ever weekly birth control patch was released into the marketplace and has since been embraced my millions of enthusiastic women. In 2004, ORTH EVRA accounted for more than 9.9 million prescriptions with sales topping $411 million. Howevever, in November 2005, the U.S. Food and Drug Administration (FDA) issued a black box warning label for the ORTHO EVRA birth control patch.
ORTHO EVRA Birth Control Overview and Ortho Evra information
The Ortho Evra blood clot risk for using the weekly birth control patch is increased by women who are 35 years or older, who smoke, and by having conditions associated with heart attacks -- such as diabetes, high blood pressure, high cholesterol, and certain inherited conditions that increase the risk of blood clotting.
The most serious Ortho Evra side effects, from using the weekly Ortho Evra birth control patch, are having a blood clot that starts in your legs or lungs move to your heart or brain causing debilitating strokes, heart attacks, hemorrhage, and death. It is important to tell your surgeon that you are using the birth control patch if planning a major operation because of the significant risk on Ortho Evra blood clots. Since stroke is associated with Ortho Evra and stroke is a risk during surgery, this side effects information about Ortho Evra blood clots is very important to your surgeon.
What is ORTHO EVRA birth control? What are birth control patch side effects?
∙ ORTHO EVRA is a thin patch used for birth control.
∙ Once applied to the skin, the ORTHO EVRA patch releases a steady supply of estrogen and progestin through the skin and into the bloodstream.
∙ ORTHO EVRA exposes you to 60% more estrogen than if you used a typical birth control pill. Increased exposure may increase the risk of side effects.
Are you suffering from any of these devastating ORTHO EVRA side effects?
∙ Blood clot - Deep vein thrombosis (DVT)
∙ Blood cloth - Pulmonary embolism (PE)
∙ The potential risk of developing endometrial and breast cancer, gallbladder disease, and liver tumors.
